Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,372 shares at $213.89 ($722K) on 2021-04-05, disclosed to the SEC on 2021-04-07.
Open-market sale of $722k VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $213.89 | 1,297 | $277K | 38.4% |
| 2 | $213.89 | 1,297 | $277K | 38.4% |
| 3 | $214.99 | 389 | $84K | 11.6% |
| 4 | $214.99 | 389 | $84K | 11.6% |
| Total | $214.14 avg | 3,372 | $722K | 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |